The Successful Transition from Injectable to Inhaled Prostacyclins in the Outpatient Setting for Patients with Pulmonary Arterial Hypertension

Lucas Kimmig ,Chih‐Yi Liao ,Remzi Bag

doi:10.1016/j.healun.2018.01.1277

The Successful Transition from Injectable to Inhaled Prostacyclins in the Outpatient Setting for Patients with Pulmonary Arterial Hypertension

Lucas Kimmig , Chih‐Yi Liao + Show 1 more

https://doi.org/10.1016/j.healun.2018.01.1277

Copy DOI

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Publication Date: Apr 1, 2018

Affiliation: University of Chicago

#Treatment Of Pulmonary Arterial Hypertension #Outpatient Setting For Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Prostacyclin treatment of pulmonary arterial hypertension (PAH) was cumbersome and limited to continuous intravenous (IV) or subcutaneous (SQ) infusion for years. Limited data exists regarding transition from injectable to inhaled prostanoid ever since its availability.

Full Text